Analyst Viewpoint
Increase in demand for non-toxic biological catalysts in diagnostics and pharmaceutical industries is positively influencing the global diagnostic specialty enzymes market value. Enhancements in tools intended to optimize production in the pharmaceutical sector are boosting the adoption of specialty enzymes.
Surge in awareness regarding the multi-functional benefits of specialty enzymes and innovations in terms of technologies aimed at reducing the consumption of chemically produced catalysts are fueling the diagnostic specialty enzymes market size.
Players operating in the global specialty enzymes industry are engaged in various corporate development and expansion strategies, such as mergers and acquisitions, portfolio expansion, and new product launches, to amass a lucrative industry position.
Enzymes are natural biocatalysts, produced and harvested from living organisms such as plants, animals, bacteria, and fungi. Diagnostic specialty enzymes are used in low-volume and high-value-added applications. Applications of diagnostic specialty enzymes include clinical chemistry, molecular diagnostics, and immunoassay.
Solutions in the diagnostic specialty enzymes market landscape are used in processing applications of DNA and RNA polymers such as replication, recombination, transcription, and repair. Proteases, polymerases, lipases, nucleases, and carbohydrase, including cellulases and amylases, are various types of specialty enzymes. These products can be sourced from three primary sources, namely, plants, microorganisms, and animals.
Biocatalysts have been considered to be low-toxic and eco-friendly catalysts that reveal site- and enantioselectivity for specific substrates in various transformations. These catalysts place substrates in ideal positions to each other. This facilitates precise control of the reaction resulting in high chemo- and stereoselectivity.
Biocatalysts offer properties such as low toxicity, biodegradability, excellent selectivity, and good catalytic performance under mild reaction conditions. Thus, they are often regarded as green catalysts compared to conventional chemical catalysts in organic synthesis.
Nucleases and polymerases are widely employed in a variety of end-use industry verticals such as research, diagnostics, biocatalysts, biotechnology, and pharmaceuticals. Nucleases are used in molecular biology research to fragment DNA or RNA for various experiments including gene cloning, sequencing, and mapping.
Hence, rise in investment in molecular biology is augmenting the diagnostic specialty enzymes market share. In June 2023, Merck announced plans to create nearly 500 jobs in Scotland as part of a £30 Mn investment in two drug testing sites. The investment includes a new 1,200 sq m facility in Glasgow, which will house molecular biology and sequencing services.
Specialty enzymes play a crucial role in various diagnostic assays and tests. They are employed in the diagnosis of various diseases such as cancer, cardiovascular diseases, and infectious diseases.
In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths were projected to occur in the U.S., according to the National Institutes of Health. Several studies are proposing potential inhibitors targeting various enzymes to prevent cancer cell growth and proliferation.
Surge in investment in drug manufacturing and disease diagnostics is expected to spur the specialty enzymes market growth during the forecast period. In October 2023, Imeka announced an investment from the Alzheimer’s Drug Discovery Foundation (ADDF) to accelerate the development of novel biomarkers for Alzheimer's disease and related dementias.
The investment will support the use of Imeka neuroimaging biomarkers in a large-scale, longitudinal study of dementia markers and their progression from pre-symptomatic stages to the onset of Alzheimer’s disease and other types of dementia.
Specialty enzymes are employed in various diagnostic applications such as DNA manipulation and sequencing. A decline in the cost of DNA manipulation and sequencing is projected to drive demand and increase the usage of enzymes in biotechnology and diagnostic applications. Increase in geriatric population is augmenting the diagnostic specialty enzymes market development.
The demand for specialty enzymes used in diagnostic applications is likely to rise as the global population ages.According to the latest diagnostic specialty enzymes market trends, diagnostic and research & biotechnology enzymes are projected to gain traction due to advancements in molecular diagnostics.
Another trend is the use of diagnostic specialty enzymes in precision medicine for the identification of genetic variations associated with diseases.
Rise in personalized medicine is also driving the demand for diagnostic and research & biotechnology enzymes. Large pharmaceutical companies are heavily investing in the R&D of new drugs, thereby propelling the diagnostic specialty enzymes market demand.
According to the latest diagnostic specialty enzymes market analysis, the polymerases & nucleases product segment held the largest share in 2022. Rise in usage of polymerise and nuclease enzymes in advanced biotech applications, such as DNA sequencing and DNA amplification, is fueling the segment.
The oxidases segment is likely to lose diagnostic specialty enzymes market share during the forecast period. In terms of application, the clinical chemistry segment is expected to continue to dominate the market from 2023 to 2031. Blood glucose monitoring was the leading sub-segment of the clinical chemistry segment in 2022 and is likely to account for major share during the forecast period.
North America accounted for the largest share in 2022. Increase in adoption of new biotechnology approaches, such as next-generation sequencing, and rise in investment in drug discovery are fueling the diagnostic specialty enzymes market dynamics of the region. Development of health care infrastructure, rise in population, growth in biotechnology sector, and increase in the burden of diseases are propelling the market trajectory in Asia Pacific.
F. Hoffmann-La Roche Ltd., Novozymes A/S, Codexis, Inc., BBI Solutions, Biocatalysts Ltd., Advanced Enzymes Technologies Ltd., American Laboratories, Inc., Thermo Fisher Scientific Inc., Amano Enzyme Inc., and Amicogen are key players operating in the global diagnostic specialty enzymes industry.
Major players, such as Codexis, Inc., Amano Enzymes, Inc., Biocatalysts Ltd., and Advanced Enzymes Technologies Ltd., have a strong presence in the global market. In the past few years, the market has witnessed high investments by various multinational enzyme manufacturers such as F. Hoffmann-La Roche Ltd., Novozymes, Codexis, and Biocatalysts.
Each of these companies has been profiled in the diagnostic specialty enzymes market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 1.0 Bn |
| Market Forecast (Value) in 2031 | US$ 1.8 Bn |
| Growth Rate (CAGR) | 6.9% |
| Forecast Period | 2023-2031 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 1.0 Bn in 2022
It is anticipated to grow at a CAGR of 6.9% from 2023 to 2031
Increase in demand for non-toxic biological catalysts and rise in prevalence of diseases
The polymerases & nucleases segment held the largest share in 2022
North America was the leading region in 2022
F. Hoffmann-La Roche Ltd., Novozymes A/S, Codexis, Inc., BBI Solutions, Biocatalysts Ltd., Advanced Enzymes Technologies Ltd., American Laboratories, Inc., Thermo Fisher Scientific Inc., Amano Enzyme Inc., and Amicogen
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diagnostic Specialty Enzymes Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Proteases
6.3.2. Carbohydrases
6.3.3. Polymerases & Nucleases
6.3.4. Oxidases
6.3.5. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Clinical Chemistry
7.3.1.1. POC Testing
7.3.1.2. Blood Glucose Monitoring
7.3.1.3. Others
7.3.2. Molecular Diagnostics
7.3.3. Immunoassay
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Diagnostic Specialty Enzymes Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Product, 2017–2031
9.3.1. Proteases
9.3.2. Carbohydrases
9.3.3. Polymerases & Nucleases
9.3.4. Oxidases
9.3.5. Others
9.4. Market Value Forecast, by Application, 2017–2031
9.4.1. Clinical Chemistry
9.4.1.1. POC Testing
9.4.1.2. Blood Glucose Monitoring
9.4.1.3. Others
9.4.2. Molecular Diagnostics
9.4.3. Immunoassay
9.4.4. Others
9.5. Market Value Forecast, by Country, 2017–2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Application
9.6.3. By Country
10. Europe Diagnostic Specialty Enzymes Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Proteases
10.3.2. Carbohydrases
10.3.3. Polymerases & Nucleases
10.3.4. Oxidases
10.3.5. Others
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Clinical Chemistry
10.4.1.1. POC Testing
10.4.1.2. Blood Glucose Monitoring
10.4.1.3. Others
10.4.2. Molecular Diagnostics
10.4.3. Immunoassay
10.4.4. Others
10.5. Market Value Forecast, by Country/Sub-region, 2017–2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By Country/Sub-region
11. Asia Pacific Diagnostic Specialty Enzymes Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Proteases
11.3.2. Carbohydrases
11.3.3. Polymerases & Nucleases
11.3.4. Oxidases
11.3.5. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Clinical Chemistry
11.4.1.1. POC Testing
11.4.1.2. Blood Glucose Monitoring
11.4.1.3. Others
11.4.2. Molecular Diagnostics
11.4.3. Immunoassay
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By Country/Sub-region
12. Latin America Diagnostic Specialty Enzymes Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Proteases
12.3.2. Carbohydrases
12.3.3. Polymerases & Nucleases
12.3.4. Oxidases
12.3.5. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Clinical Chemistry
12.4.1.1. POC Testing
12.4.1.2. Blood Glucose Monitoring
12.4.1.3. Others
12.4.2. Molecular Diagnostics
12.4.3. Immunoassay
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By Country/Sub-region
13. Middle East & Africa Diagnostic Specialty Enzymes Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Proteases
13.3.2. Carbohydrases
13.3.3. Polymerases & Nucleases
13.3.4. Oxidases
13.3.5. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Clinical Chemistry
13.4.1.1. POC Testing
13.4.1.2. Blood Glucose Monitoring
13.4.1.3. Others
13.4.2. Molecular Diagnostics
13.4.3. Immunoassay
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. F. Hoffmann-La Roche Ltd.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Novozymes A/S
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Codexis, Inc.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. BBI Solutions
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Biocatalysts Ltd.
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Advanced Enzymes Technologies Ltd.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. American Laboratories, Inc.
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Thermo Fisher Scientific Inc.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. Amano Enzyme Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. Amicogen
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview
List of Tables
Table 01: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 06: North America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 07: Europe Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 09: Europe Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 10: Asia Pacific Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 12: Asia Pacific Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 13: Latin America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Latin America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031
List of Figures
Figure 01: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Diagnostic Specialty Enzymes Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Diagnostic Specialty Enzymes Market Value Share, by Product, 2022
Figure 04: Global Diagnostic Specialty Enzymes Market Revenue (US$ Mn), by Application, 2022
Figure 05: Global Diagnostic Specialty Enzymes Market Value Share, by Application, 2022
Figure 06: Global Diagnostic Specialty Enzymes Market Value Share, by Region, 2022
Figure 07: Global Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast, 2023–2031
Figure 08: Global Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031
Figure 09: Global Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031
Figure 10: Global Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031
Figure 11: Global Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031
Figure 12: Global Diagnostic Specialty Enzymes Market Value Share Analysis, by Region, 2022–2031
Figure 13: Global Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Region, 2023–2031
Figure 14: North America Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 15: North America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country, 2023–2031
Figure 16: North America Diagnostic Specialty Enzymes Market Value Share Analysis, by Country, 2022–2031
Figure 17: North America Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031
Figure 18: North America Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031
Figure 19: North America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031
Figure 20: North America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031
Figure 21: Europe Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 22: Europe Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 23: Europe Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 24: Europe Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031
Figure 25: Europe Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031
Figure 26: Europe Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031
Figure 27: Europe Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031
Figure 28: Asia Pacific Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 29: Asia Pacific Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 30: Asia Pacific Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 31: Asia Pacific Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031
Figure 32: Asia Pacific Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031
Figure 33: Asia Pacific Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031
Figure 34: Asia Pacific Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031
Figure 35: Latin America Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 36: Latin America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 37: Latin America Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 38: Latin America Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031
Figure 39: Latin America Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031
Figure 40: Latin America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031
Figure 41: Latin America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031
Figure 42: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 43: Middle East & Africa Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 44: Middle East & Africa Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 45: Middle East & Africa Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031
Figure 46: Middle East & Africa Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031
Figure 47: Middle East & Africa Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031
Figure 48: Middle East & Africa Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Diagnostic Specialty Enzymes Market
*86 figures and 60 tables includes